LBNL Logo ONHS Funding Opportunity Report

MTEC Solicitation Summary: Fiscal Year 2026 Multi-Topic Request for Project Proposals

Solicitation ID: MTEC-26-04-MultiTopic

Agency: Department of Defense

Type: Special Notice
Deadline: 2026-10-30T12:00:00 ET
Eligibility: Maybe (OTA/Consortium)
Funding: The average size of MTEC awards for the initial period of performance is approximately $2.0M – $3.5M over a 2-3-year period.
Doc Type: RFP
Clearance: No
Program Manager: chuck.hutti@mtec-sc.org
Last Updated: 2026-08-07 16:03
Analyzed File: MTEC-26-04-MultiTopic RPP Announcement.pdf

Eligibility Reasoning

Awards resulting from this RPP are expected to be made under the authority of 10 U.S.C. § 4022 (Authority of the Department of Defense to carry out certain prototype projects). MTEC is a biomedical technology consortium collaborating with multiple government agencies under a 10-year renewable Other Transaction Agreement (OTA), Agreement No. W81XWH-15-9-0001, with the Defense Health Agency Contracting Activity (DHACA).

Note: This is an AI-generated summary...

Summary

The Medical Technology Enterprise Consortium (MTEC) is soliciting prototype projects for its Fiscal Year 2026 Multi-Topic Request for Project Proposals (MTEC-26-04-MultiTopic). The RPP seeks medical technology and knowledge solutions with military relevance across 15 distinct focus areas, including behavioral health, infectious disease prevention and treatment (wound infections, sepsis, diarrhea, Dengue, emerging viruses), musculoskeletal injury, pain management (novel non-addictive analgesics, repurposed drugs), advanced anesthesia, and blast exposure monitoring. Proposals must address only one focus area, be for a prototype (minimum TRL/KRL of 3), and not have been submitted to MTEC within the last two years. The acquisition process begins with an Enhanced White Paper submission from MTEC members, with selected offerors invited to submit a full cost proposal. Average awards are typically $2.0M - $3.5M over a 2-3 year period, with potential for non-competitive follow-on work.

Overall Technical Areas

Wound Infection ProphylaxisSepsis Treatment CountermeasuresImmunotherapeutics DevelopmentClinical Guideline OptimizationBacterial Disease PreventionInfectious Disease TherapeuticsBroad-Spectrum AntiviralsMusculoskeletal Injury TreatmentHuman Performance Data AnalysisNovel Drug Delivery SystemsPreclinical Analgesic DevelopmentAdvanced Anesthesia SystemsBlast Exposure Sensor DevelopmentBiomechanical Response ModelingNeurocognitive Assessment Technology

Probable LBNL Areas

BSAESAETA· Repurposing and Novel Delivery of Approved Compounds

Focus Areas

Example Priorities:
  • Policies and practices for cross-cutting prevention
  • Fostering Service member physical fitness through integrated primary prevention
  • Identify and reduce barriers to help-seeking
  • Prophylactic Solutions to Prevent Battlefield and Complex Traumatic Wound Infections in Austere or Contested Environments
  • Pathogen Agnostic Countermeasures for the Treatment of Sepsis Caused by Wound Infection
  • Knowledge Product Prototypes for the Prevention of Infection in Traumatic Penetrating Wounds
  • Bacterial Diarrhea Prevention
  • Dengue Fever Prevention and/or Treatment Solutions
  • Prevention and Treatment of Emerging Infectious Diseases
  • Musculoskeletal Injury Treatment
  • Operational Suitability of Existing Pain Treatments
  • Repurposing and Novel Delivery of Approved Compounds
  • Development of Novel Non-Addictive Analgesics
  • Advanced Anesthesia and Procedural Pain Solutions
  • Blast and Blunt Sensors for Exposure Monitoring
Specific Technical Skills:
Policies and practices for cross-cutting preventionFostering Service member physical fitness through integrated primary preventionIdentify and reduce barriers to help-seekingProphylactic Solutions to Prevent Battlefield and Complex Traumatic Wound Infections in Austere or Contested EnvironmentsPathogen Agnostic Countermeasures for the Treatment of Sepsis Caused by Wound InfectionKnowledge Product Prototypes for the Prevention of Infection in Traumatic Penetrating WoundsBacterial Diarrhea PreventionDengue Fever Prevention and/or Treatment SolutionsPrevention and Treatment of Emerging Infectious DiseasesMusculoskeletal Injury TreatmentOperational Suitability of Existing Pain TreatmentsRepurposing and Novel Delivery of Approved CompoundsDevelopment of Novel Non-Addictive AnalgesicsAdvanced Anesthesia and Procedural Pain SolutionsBlast and Blunt Sensors for Exposure Monitoring
Potential PIs for this Area:
NameScoreOrganization
Natalia Molchanova0.71ESA | MF | MF Biological Facility · Prophylactic Solutions to Prevent Battlefield and Complex Traumatic Wound Infections in Austere or Contested Environments
Sunita Ho0.70ESA | ALS | Users · Musculoskeletal Injury Treatment
Jennifer Rosenbluth0.70 · Repurposing and Novel Delivery of Approved Compounds
Zachary Jones0.70BSA | Biological Systems & Engineering | Process Engr & Analytics · Blast and Blunt Sensors for Exposure Monitoring
Jay Nix0.69ESA | ALS | ALS Photon Science Operations · Prevention and Treatment of Emerging Infectious Diseases
Gerard Marriott0.68BSA | Molecular Biophysics & Integrated Bioimaging | Cellular & Tissue Image · Advanced Anesthesia and Procedural Pain Solutions
Michelle O'Malley0.68BSA | Biological Systems & Engineering | Biodesign Dept · Knowledge Product Prototypes for the Prevention of Infection in Traumatic Penetrating Wounds
Deepika Awasthi0.68BSA | Biological Systems & Engineering | Biodesign Dept · Pathogen Agnostic Countermeasures for the Treatment of Sepsis Caused by Wound Infection
Alan Meier0.68ETA | Building Tech. & Urban Sys. | Bldg Technologies Dept · Policies and practices for cross-cutting prevention
Kenneth Wan0.68ESA | CSD | Other Program · Fostering Service member physical fitness through integrated primary prevention

Potential LBNL PIs (Overall)

Note on PI Matching: These suggestions are generated through an AI-driven semantic analysis of LBNL staff profiles.

NameScoreOrganization
Natalia Molchanova0.74ESA | MF | MF Biological Facility · Infectious Disease Therapeutics
Mohammad Kaazem Pur Mofrad0.73BSA | Molecular Biophysics & Integrated Bioimaging | Structural Biology Dept · Biomechanical Response Modeling
Gerard Marriott0.73BSA | Molecular Biophysics & Integrated Bioimaging | Cellular & Tissue Image · Novel Drug Delivery Systems
Reginald Lee0.73PSA | Engineering | Mechanical Engineering · Musculoskeletal Injury Treatment
Banumathi Sankaran0.72BSA | Molecular Biophysics & Integrated Bioimaging | Structural Biology Dept · Immunotherapeutics Development
Victor Negut0.72PSA | NSD | ANP · Blast Exposure Sensor Development
Kevin Fan0.72LD | LD | Strategic Partnerships · Neurocognitive Assessment Technology
Harry Caufield0.71BSA | Env. Genomics & Sys. Biology | BioSystems Data Science · Clinical Guideline Optimization
Travis Walter0.71ETA | Building Tech. & Urban Sys. | Whole Building Sys Dept · Human Performance Data Analysis
Claire Tomlin0.71BSA | Biological Systems & Engineering | Department of BioEngineering and BioMedical Sciences · Advanced Anesthesia Systems

Fundamental Research Exemption (FRE)

Not Mentioned